GlassScriptPhysician profile
Bailey Stephenson
NPI 1720661580
$907.86
in general payments reported to CMS, 2019-2025
17 companies · $214 in 2025
The $214 reported for 2025 was more than what 76% of Registered Nurse providers received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $364 · 2024: $330 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $218.29 | 2023-2025 | Prolaris |
| Sumitomo Pharma America, INC. | $113.63 | 2023-2024 | Orgovyx, Gemtesa |
| Abbvie INC. | $93.63 | 2025 | |
| Dendreon Pharmaceuticals LLC | $90.87 | 2023-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $49.93 | 2023-2024 | |
| 180 Medical, INC. | $47.51 | 2023 | |
| Novartis Pharmaceuticals Corporation | $44.10 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $36.13 | 2023 | Lynparza |
| Telix Pharmaceuticals | $31.13 | 2023-2024 | Illuccix |
| Janssen Biotech, INC. | $27.82 | 2023 | Erleada |
| Urogen Pharma, INC. | $26.59 | 2025 | |
| Merck Sharp & Dohme LLC | $26.19 | 2024 | Keytruda |
| Endo Pharmaceuticals INC. | $21.70 | 2024 | Xiaflex |
| Endo USA, INC. | $20.66 | 2024 | Xiaflex |
| C. R. Bard, INC. & Subsidiaries | $20.41 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $19.77 | 2024 | Myrbetriq |
| Antares Pharma, INC. | $19.50 | 2025 | Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bailey Stephenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.